Prednisone vs Prednisolone Cats Difference

Colleague,

This is a fundamental pharmacokinetic point in feline medicine. The preference for prednisolone over prednisone in cats is based on clear evidence of poor and erratic hepatic conversion.

Here's the breakdown based on your questions:

1. Hepatic Conversion & Bioavailability:
Prednisone is a prodrug that requires conversion by hepatic 11-beta-hydroxysteroid dehydrogenase to its active metabolite, prednisolone. While dogs perform this conversion efficiently, cats do not. Pharmacokinetic studies have shown that after oral administration of prednisone to cats, the resulting plasma concentrations of prednisolone are unpredictable and significantly lower than when prednisolone itself is administered. The bioavailability of prednisolone from oral prednisone in cats can be as low as 20-50%, leading to inconsistent and often sub-therapeutic drug levels. In contrast, oral prednisolone is well-absorbed in cats, with bioavailability typically exceeding 80%. Using prednisone is essentially a gamble on whether that individual cat can convert enough of the drug to be effective. We don't guess; we use the active metabolite directly.

2. Dosing:
Dosing is based on the active drug, prednisolone. The principles are the same as in other species, but the dose varies by indication:
* Anti-inflammatory: For conditions like feline asthma or inflammatory bowel disease, a starting dose of 0.5-1.0 mg/kg PO q24h is typical.
* Immunosuppressive: For immune-mediated diseases (e.g., IMHA, pemphigus), the starting dose is higher, typically 2-4 mg/kg/day, often divided q12h initially to establish control.

Always aim for the lowest effective dose for the shortest necessary duration.

3. Tapering:
Abrupt cessation after prolonged use (>2-3 weeks) will induce iatrogenic hypoadrenocorticism. The taper must be gradual to allow the hypothalamic-pituitary-adrenal axis to recover. A common strategy for immunosuppressive doses is to reduce the total daily dose by 25-50% every 2-4 weeks, guided by clinical remission. For anti-inflammatory doses, the taper can often be faster.

4. Side Effects & Monitoring:
Cats are generally more resistant to the classic PU/PD and polyphagia side effects than dogs, but they are uniquely susceptible to steroid-induced diabetes mellitus due to insulin resistance. This is the most significant long-term risk. Steroids can also unmask or worsen subclinical hypertrophic cardiomyopathy (HCM) due to fluid retention.

Monitoring Schedule for Long-Term Use (e.g., >1 month):
* Baseline: Chemistry panel, CBC, urinalysis.
* Every 3-6 months:
* Chemistry Panel: Pay close attention to glucose. A fructosamine level is more reliable for detecting persistent hyperglycemia than a single spot glucose.
* Urinalysis: Screen for glucosuria (a red flag for diabetes) and occult UTIs, as steroids can mask clinical signs of infection.
* Body Weight & Muscle Condition Score: Monitor for catabolic effects.
* Blood Pressure: Check periodically, as glucocorticoids can contribute to hypertension.

In short, prescribe prednisolone. It eliminates the key variable of poor hepatic conversion, ensuring you achieve predictable therapeutic levels.

Dr. Nadia Voss

Colleague,

This is a critical point in feline medicine. The recommendation to use prednisolone over prednisone in cats is based on fundamental species differences in glucocorticoid metabolism.

The core reason is the poor and often erratic hepatic conversion of prednisone (a pro-drug) to its active metabolite, prednisolone. While dogs perform this conversion efficiently, studies have shown that cats have significantly lower bioavailability and achieve lower peak plasma concentrations of prednisolone after oral administration of prednisone. This makes prednisone an unreliable choice, as you may not achieve therapeutic levels, especially when managing a critical immune-mediated disease. Using prednisolone bypasses this inefficient conversion step entirely, ensuring more predictable absorption and reliable blood levels.

For clinical application, here's how I approach it:

* Dosing:
* Anti-inflammatory: 0.5-1 mg/kg/day. Useful for conditions like IBD or chronic bronchitis.
* Immunosuppressive: 2-4 mg/kg/day, often divided BID initially for severe diseases like pemphigus foliaceus or immune-mediated hemolytic anemia. I start high and taper as the disease comes under control.

* Tapering: The goal is to find the lowest effective dose that controls clinical signs. My typical taper for a stable patient involves a 25-50% dose reduction every 2-4 weeks, often transitioning to every-other-day therapy once the daily dose is low. This is highly dependent on the disease being treated and the patient's response. Abrupt cessation will induce iatrogenic hypoadrenocorticism.

* Side Effects & Monitoring: While cats are more resistant to the PU/PD/PP seen in dogs, they are uniquely at risk for steroid-induced diabetes mellitus, especially with high-dose or long-term use. This risk is amplified in overweight cats.
* Monitoring Schedule: For any cat on chronic prednisolone, I recommend a recheck every 3-6 months. This includes a thorough physical exam (paying close attention to weight and muscle condition), baseline blood glucose, and a urinalysis to screen for glucosuria or occult UTIs. Fructosamine can be a useful adjunct if there's any concern for developing hyperglycemia.

Ultimately, using prednisolone removes a major variable of unpredictable drug metabolism. It's a simple substitution that significantly improves our therapeutic reliability in feline patients.